Trial Profile
A retrospective study evaluating Perampanel in patients with drug resistant epilepsy and cognitive impairment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2017
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy; Generalised epilepsy; Lennox-Gastaut syndrome
- Focus Adverse reactions; Therapeutic Use
- 04 Sep 2017 New trial record